|1.||Elley, C Raina: 2 articles (01/2010 - 01/2010)|
|2.||Warren, Jim: 2 articles (01/2010 - 01/2010)|
|3.||Kennelly, John: 2 articles (01/2010 - 01/2010)|
|4.||Paton, Chris: 2 articles (01/2010 - 01/2010)|
|5.||Mabotuwana, Thusitha: 2 articles (01/2010 - 01/2010)|
|6.||Wells, Stewart: 2 articles (01/2010 - 01/2010)|
|7.||Ozturk, Gunseli: 1 article (01/2015)|
|8.||Yaman, Banu: 1 article (01/2015)|
|9.||Iskandarli, Mehdi: 1 article (01/2015)|
|10.||Gerceker Turk, Bengu: 1 article (01/2015)|
|1.||Hypertension (High Blood Pressure)
01/01/1999 - "In conclusion, correction of RAS leads to cure of or improved control of hypertension in the majority of the patients with FMD, but in the ASC group in about half of cases no BP cure or improvement was seen. "
06/01/2013 - "Individuals aged >70 years with a history of systolic hypertension on 1 or no BP lowering drugs were recruited from primary care (n=37; age, 75±4 years; systolic BP, >150 mm Hg) and randomized to receive intensive (target BP, <130/80 mm Hg) or usual (target BP, <140/85 mm Hg) BP lowering for 12 weeks, with reviews every 2 weeks. "
01/01/2010 - "Data from two New Zealand general practices was analysed on five BP control indicators for patients with diagnosed hypertension: 1) last BP high (>150/90 mmHg); 2) last BP high or no BP measurement; 3) two or more consistently high BP measurements for ≥ 90 days; 4) a high BP then lapse of >120 days in BP measurement; and 5) antihypertensive medication possession ratio (MPR) of <80%. "
01/01/2010 - "Data were analysed for three indicators with respect to a nine-month evaluation period for patients with hypertension and a 15-month period for patients with diabetes: (1) two or more consistently high BP measurements spaced over > or = 90 days, (2) a high BP measurement followed by a lapse of >120 days in BP measurement and (3) no BP measurement for >180 days. "
11/01/2009 - "Hypertension was recorded in 119.065 individuals (prevalence 19.3%), 19.134 (16%) had no ambulatory visit and 33.183 (27.8%) had no BP value recorded. "
10/01/2010 - "The primary objective of this study was to determine if the ventilatory (&OV0312;E) breakpoint during incremental exercise to fatigue is best represented by a single breakpoint (BP1), double breakpoint (BP2), or an exponential function (EXP) exhibiting no BP. A secondary objective was to determine if visual assessment of the BP was valid and reliable. "
|4.||Prostatic Neoplasms (Prostate Cancer)
03/01/2014 - "Bone scintigraphies of 42 patients with prostate cancer were retrospectively analyzed (n = 21 with BP intake; n = 21 no BP). "
03/01/2011 - "Timely ZA intervention in bone-metastatic prostate cancer patients was associated with significant reductions in 6-month risks of SREs, hospitalization and mortality, as compared with no BP treatment."